News
Ariel Investments, an investment management company, released its “Ariel Global Fund” first-quarter 2025 investor letter. A ...
Biogen Inc. (Nasdaq: BIIB) announced the initiation of dosing in the BRAVE study, a global Phase 3 clinical trial. The BRAVE study will evaluate the efficacy and safety of omaveloxolone in children ...
AI will only become more embedded in life sciences. The shift toward autonomous agents and complex, multistage processes is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback